Radio Frequency Ablation Devices Market to reach 10.72 Billion in 2030 with a CAGR of around 11.73 % asserts Strategic Market Research. Lets make you accustomed to some of the most pivotal statistics pertaining to this market.

New York, United States, May 18, 2022 (GLOBE NEWSWIRE) — Rising geriatric population and chronic diseases worldwide are the key factors that are driving the Radio Frequency Ablation Devices Market exponentially. According to the World Health Organization, the number of people aged 60 years and above will rise from 900 Million to 2 Billion between the years 2015 to 2050. In terms of End-User, the Hospital market segment possessed the maximum share of the entire market in the year 2020 with 48.12 %, and it is anticipated to do so over the forecasted period of 2020-2030. Moreover, on a regional basis, North America held the greatest proportion of the entire market, with a CAGR of 11.9% in the year 2020. However, on the other hand, the Asia-Pacific region subsumed the highest CAGR of the market throughout the projected period of 2020-2030.

To get a first-hand overview of the report, Request a Sample at 

https://www.strategicmarketresearch.com/request-sample/radiofrequency-ablation-devices-market

The segmentation outline of the latest report published by Strategic Market Research on Radio Frequency Ablation Devices Market are as follows:

Product

• RF Generators
• Disposables
• Reusables

Applications

• Surgical Oncology
• Pain Management
• Cardiology & Cardiac Rhythm Management
• Cosmetology
• Gynaecology
• Others

End-User

• Hospitals
• Ambulatory Surgical Centers
• Others

Regions

• North America
• Europe
• Asia-Pacific
• LAMEA

Make a Direct Purchase of the latest Radio Frequency Ablation Devices Market Report published in the month of December 2021. Click the below link to initiate the purchase: 

https://www.strategicmarketresearch.com/buy-now/radiofrequency-ablation-devices-market

The Market for Global Radio Frequency Ablation Devices is predicted to reach a market value of USD 10.726 billion by 2030 from USD 3.531 billion in 2020, at a CAGR of 11.73 percent during the forecasted period. Apart from the growing number of cases of CVDs and cancer, the increase in the overall demand for pain management (such as relief from arthritis and various other chronic pain disorders by medicines) is also augmenting the overall growth of the market to a great extent. Also, the market for Global Pain Management is growing smoothly at a CAGR of about 5.017 % all over the forecasted timeline of 2020-2030.

By Product, the Disposable segment held the largest share of the Radio Frequency Ablation Devices market

In terms of Product, the ‘Disposable’ market segment had the largest market share in the year 2020 with a steady CAGR. The minimization of mortality and morbidity rates worldwide & the overall ability of the RFA devices to provide treatment in an outpatient setting are all propelling the growth of this entire market segment.

By Application, the ‘Surgical Oncology’ market segment possessed the highest share of the market

In terms of Applications, the ‘Surgical Oncology market segment possessed the largest market share in the year 2020. The sole aim of surgical oncology is to eradicate the cancerous tissues that are present within the whole body. In accordance with the BIBB INSTRUMENTS, over 1 Million biopsies are well-conducted each year all throughout the globe with the assistance of EUS fine-needle instruments. Also, in the U.S itself, there are over 1200 hospitals which are busy in implementing the endoscopy ultrasound to diagnose the cancer patients particularly.

By End-User, the ‘Hospitals’ dominated the entire Radio Frequency Ablation Devices Market

In terms of End-User, the ‘Hospital market segment comprehensively dominated the entire market in the year 2020 with an overall share of 48.12 percent, and it is expected to continue to do so all over the forecasted period of 2020-2030. As per Definitive Healthcare, the hospitals in the United States spent a total sum of USD 36 Billion on medical supplies in the year 2018, with an average of almost USD 11.9 Million per hospital.

North America held the maximum portion of the Radio Frequency Ablation Devices Market share

On a regional basis, North America contained the largest proportion of the total market with an overall CAGR of 11.973% and overall revenue of 1.513 Billion in the year 2020.  It is mostly because of the crucial factors like rapid growth in the technological advancements in RFA & other medical devices, the continuous rising prevalence of cancer cases, and the expenditure by the governmental bodies on the healthcare facilities that are widely stimulating the total growth of this market. However, on the other hand, the Asia-Pacific region held the highest CAGR of the market all over the projected period of 2020-2030. It is mainly because of the introduction of new technologies like multi-needle electrodes and quick improvements of the whole healthcare infrastructures in China and India, which are all widely stimulating the growth of the market in this entire region.

Before initiating a purchase, make a Pre-order enquiry and get a detailed overview of the content of the report

https://www.strategicmarketresearch.com/pre-order-enquiry/radiofrequency-ablation-devices-market

The major players that are covered in the Global Radio Frequency Ablation Devices Market report are:

• Halyard Health
• Boston Scientific Corporation
• St. Jude Medical
• Medtronic Plc
• Stryker Corporation
• C. R. Bard
• Hologic
• AtriCure
• AngioDynamics
• Johnson & Johnson
• Baylis Medical
• Arthrex
• Inomed Medizintechnik GmbH
• Bramsys Indústria e ComércioLtda
• ENDO-FLEX GmbH
• Sutter Medizintechnik Gmbh
• Epimed International
• Sfm Medical Devices Gmbh

Global Radiofrequency Ablation Devices Market: Recent Developments

• On the 1^st of June, 2020, Boston Scientific introduced the DIRECTSENSE Technology, which has mainly provided the electrophysiologists with the first-ever visualization and local measurement of the tissue responses to the RFA.
• On the 27^th of Feb, 2019, Medtronic received the FDA clearance to inaugurate the Accurian radiofrequency ablation platform, which is highly efficient in terms of conducting RF ablation of the nerve tissues. 
• On the 29^th of Apr, 2021, AtriCure received the FDA approval for the introduction of its Epi sense system primarily for the treatment purposes of patients who are diagnosed with persistent and long-standing Atrial Fibrillation. In accordance with the National Library of Medicine, Atrial fibrillation is one of the most frequent types of cardiac arrhythmia. It has been estimated that around (6 to 12) Million people all over the globe will suffer from this condition in the U.S. by the year 2050 and approximately 17.9 Million people in Europe by the year 2060.

Kindly go through and get access to our comprehensive coverage of myriad number of healthcare reports published in the last three months: 
https://www.strategicmarketresearch.com/reports/healthcare

Related Reports

Global Hemostats and Tissue Sealants Report

The latest report on “Hemostats and Tissue Sealants Market” Insights & Forecast 2030 published by Strategic Market Research delivers a 360-degree perspective of the various market insights. The market was valued at 6.35 Billion in 2020, and it’s anticipated to rise up to 11.27 Billion by 2028 with a promising CAGR of 8.93 %.The various factors that are expediting the market growth significantly are the increasing occurrences in adhesion prevention, the rise of applications in drug delivery mechanisms,etc. Some of the key companies that are associated with the market are Baxter, Integra Life Sciences Corporation, Advanced Medical Solutions Group plc, B Braun Medical Inc, Cohera Medical Inc,CryoLife Inc, C.R. Bard Inc, Johnson & Johnson Services Inc, Pfizer Inc, Cohesion Technologies Inc, etc.

Global Multiplex Assays Market Report

Comprehensive report on “Multiplex Assays Market” Insights & Forecast 2030 published by Strategic Market Research delivers a crystal clear idea of the key market insights. The market was valued at 3.13 Billion in 2020, and it’s estimated to increase up to 6.47 Billion by 2030 with a decent CAGR of 7.53 %. The most significant drivers of this market are the increase of chronic and infectious diseases, the increase in the awareness of disease diagnosis, the growing prevalence of multiplex assays in companion diagnostics, the need for effective analytical platforms in R&D, few among others. Dominant players in the Global Multiplex Assays Market are Luminex Corporation, Bio-Rad Laboratories, Inc, Qiagen N.V., Thermo Fisher Scientific Inc, Abcam plc, Merck KGaA, Agilent Technologies, Inc, Becton, Randox Laboratories, Dickinson and Company, Illumina Inc, Meso Scale Diagnostics, Quanterix, Bio-Techne Corporation, Olink, DiaSorin S.p.A., Seegene, Promega Corporation, Siemens Healthineers.

Global Single Cell Analysis Market Report

The report on “Single Cell Analysis Market” Insights & Forecast 2030 published by Strategic Market Research elucidates a concrete understanding of the pivotal market insights. The market was valued at 2.42 Billion in 2020, and it’s expected to rise up to a benchmark of 6.45 Billion by 2028 with a robust CAGR of 15.6 %.Some of the most significant factors that are driving the market are the rising focus on personalized medicine, increase in the technological advancements in single-cell analysis products, advanced R&D in the single-cell analysis field, quick progress in the healthcare segment worldwide, etc. The most prominent players operating in the market are Thermo Fisher Scientific Inc., QIAGEN NV, Bio-Rad Laboratories Inc., Illumina Inc., Merck Millipore, Becton, Dickinson & Company, Fluidigm Corporation, 10x Genomics, Inc., BGI, Novogene Corporation.

Global Minimally Invasive Surgical Instruments Market Report

The vital report on “Minimally Invasive Surgical Instruments Market” Insights & Forecast 2030 published by Strategic Market Research asserts a concrete understanding regarding the pivotal market insights. The market was valued at 20.878 Billion in 2020, and it’s assumed to grow up to 41.767 Billion by 2030 with a decent CAGR of 7.214 %.The increase in surgical procedures and the growing geriatric population worldwide are the key drivers that are augmenting the overall growth of the market. Promising players in the Global Minimally Invasive Surgical Instruments Market are Medtronic plc, Stryker Corporation, Johnson & Johnson, Smith & Nephew plc, Abbott Laboratories, Inc., B. Braun Melsungen AG, CONMED Corporation, Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Becton, Dickinson and Company, The Cooper Companies Inc, HOYA Corporation, Surgical Innovations Group plc, Koninklijke Philips N.V., Fujifilm Holdings Corporation.

Global Live Cell Imaging Market Report

Updated report on “Live Cell Imaging Market” Insights & Forecast 2030 published by Strategic Market Research delineates a concrete understanding of the key market insights. The market was valued at 1.8 Billion in 2020, and it’s predicted to reach up to 4.18 Billion by 2030 with a CAGR of 8.8%.The growing demand for various live-cell imaging technologies and the high mortality rate associated with CVDs are the significant drivers of the Live Cell Imaging Market. The major players operating in the Global Live cell imaging market are Danaher Corporation, Carl Zeiss AG, Nikon Corporation, Olympus Corporation, PerkinElmer, Inc., G.E. Healthcare, Bruker Corporation, Thermo Fisher Scientific Inc., Sartorius AG, Oxford Instruments, BioTek Instruments, Etaluma Inc., CytoSMART Technologies, NanoEnTek Inc., Phase Focus Limited, Tomocube Inc.

Global DNA Sequencing Market Report

Report on “DNA Sequencing Market” Insights & Forecast 2030 published by Strategic Market Research delivers a detailed understanding of the crucial market insights. The market was valued at 9 Billion in 2020, and it’s forecasted to reach a landmark of up to 44 Billion by 2030 with a comprehensive CAGR value of 17.12%. Technological improvements in DNA sequencing is the primary driver of the DNA Sequencing Market. Some of the pivotal players operating in the DNA sequencing market include Agilent Technologies, Inc.; Thermo Fisher Scientific, Inc.; Illumina, Inc.; QIAGEN; F. Hoffmann-La Roche Ltd.; Oxford Nanopore Technologies Ltd.; Macrogen, Inc.; Perkin Elmer, Inc.; Pacific Biosciences of California, Inc.; BGI; Bio-Rad Laboratories, Inc.; Myriad Genetics; PierianDx; Eurofins Scientific; and Intrexon Bioinformatics Germany GmbH.

Global Recombinant Protein Market Report

The vital report on “Recombinant Protein Market” Insights & Forecast 2030 published by Strategic Market Research deciphers a complete idea about the significant market insights. The market was valued at 1.5 Billion in 2020, and it’s likely to expedite up to 3.93 Billion by 2030 with a promising CAGR of 10.12%.The need to minimise the high frequency of viral illnesses, includinghepatitis B, human papillomavirus, CoVid-19, and others, are the key drivers that are fueling the growth of the market.The most vital players in the Global Recombinant Protein industry are Thermo Fisher Scientific, Inc. (the US), R&D Systems (US), Abcam plc (UK), Merck KGaA (Germany), and Proteintech Group, Inc. (the US), Janssen-Cilag Pty Ltd., Aviva Systems Biology, Bio-Techne Corporation (US), Elpiscience BioPharma, Eli Lilly and co., GigaGen Inc.

Global Soft Tissue Repair Market Report

The vital report on “Soft Tissue Repair Market” Insights & Forecast 2030 published by Strategic Market Research exaggerates a well-developed idea regarding the different market insights. The market was valued at 11.82 Billion in 2020, and it’s anticipated to grow up to 22.84 Billion by 2030 with a CAGR of 6.81%. Growth in the geriatric population and the increase in the demand for orthopaedic surgeries are the primary amplifiers that are propelling the market forward.The most vital players in the Global Soft tissue repair industry are Smith & Nephew Plc., Arthrex, Inc., Stryker Corporation, Johnson & Johnson, Medtronic Plc., LifeNet Health, Inc., Becton, Dickinson and Company, Integra LifeSciences Corporation, CryoLife, Inc., Organogenesis Inc., Zimmer Biomet, Baxter International, Inc., ACell Inc., Tissue Regenix Group Plc, Aroa Biosurgery Ltd., and Orthofix Medical Inc.

Global Cell Counting Market Report

The report on “Cell Counting Market” Insights & Forecast 2030 published by Strategic Market Research encompasses a pellucid understanding of the various market insights. The market was valued at 9.8 Billion in 2020, and it’s poised to grow up to 19.27 Billion by 2030 with an overall CAGR of 7%.The primary drivers of this Cell Counting Market are the rise in the technical developments in cell counting equipment or reagents and the increase in infectious illness cases. Some of the key players are Merck KGaA, PerkinElmer Inc, Olympus Corporation, HORIBA Ltd, Logos Biosystems Inc, Corning Incorporated, Tecan Trading AG, Abbott, General Electric Company, Boule Diagnostics AB.

About Us:
Strategic Market Research facilitates the organizations globally in taking pivotal business decisions by furnishing the Syndicated and Customized Research Reports, which are highly precise in terms of market numbers. We believe that every firm, whether it is a startup which is in the Introduction stage of the Product Life cycle or an established one which is at the growth stage, requires market research services in order to streamline its key business blueprint. It may be related to Product Launch, Go to Market strategies, Competitive Analysis or new geographical penetration and expansion.

Contact Us:
Strategic Market Research LLP.
Sunil Kumar 
US: +1-8317045538
UK: +441256636046
India: +91-8260836500
Email: [email protected]
Web: https://www.strategicmarketresearch.com
Blog: https://www.strategicmarketresearch.com/blog
Press Release: https://www.strategicmarketresearch.com/press-releases

Connect Us:
LinkedIn: https://www.linkedin.com/company/strategic-market-research/
Twitter: https://twitter.com/smrstrategic
Facebook: https://www.facebook.com/StrategicMarketResearch
Instagram: https://www.instagram.com/strategicmarketresearchsmr/